Cargando…

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease

The detection of lipoprotein(a) [Lp(a)] in the artery wall at the stage of lipid-bands formation may indicate that it participates in the atherosclerosis local nonspecific inflammatory process. Innate immune cells are involved in atherogenesis, with monocytes playing a major role in the initiation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afanasieva, Olga I., Tyurina, Alexandra V., Klesareva, Elena A., Arefieva, Tatiana I., Ezhov, Marat V., Pokrovsky, Sergei N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876319/ https://www.ncbi.nlm.nih.gov/pubmed/35207757 http://dx.doi.org/10.3390/jpm12020269

Ejemplares similares

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2023)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
por: Afanasieva, Olga I., et al.
Publicado: (2021)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
por: Ezhov, Marat, et al.
Publicado: (2019)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases
por: Ezhov, Marat V., et al.
Publicado: (2021)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)
por: Afshar, Mehdi, et al.
Publicado: (2016)

Socioeconomic status, cardiovascular risk profile, and premature coronary heart disease
por: Khan, Safi U., et al.
Publicado: (2022)

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, Artem, et al.
Publicado: (2023)

Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
por: Ezhov, Marat V., et al.
Publicado: (2023)

Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease
por: Chen, Bo-Wen, et al.
Publicado: (2022)

A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia
por: Vasiluev, Petr Andreevich, et al.
Publicado: (2022)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
por: Ezhov, Marat V., et al.
Publicado: (2023)

The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk
por: Higashioka, Mayu, et al.
Publicado: (2021)

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, A. G., et al.
Publicado: (2020)

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma
por: Dmitrieva, O. A., et al.
Publicado: (2021)

Family history of cardiovascular disease and risk of premature coronary heart disease: A matched case-control study
por: Chacko, Manas, et al.
Publicado: (2020)

Lipoprotein (a) and coronary heart disease – is there an efficient secondary prevention?
por: Mellwig, Klaus-Peter, et al.
Publicado: (2017)

Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
por: Colantonio, Lisandro D., et al.
Publicado: (2022)

CRP Is Transported by Monocytes and Monocyte-Derived Exosomes in the Blood of Patients with Coronary Artery Disease
por: Melnikov, Ivan, et al.
Publicado: (2020)

Comparison of 5-Year Outcomes for Patients With Coronary Artery Disease in Groups With and Without Revascularization With Different Results of Stress Echocardiography
por: Zagatina, Angela, et al.
Publicado: (2013)

Association of lipoprotein lipase gene with coronary heart disease in Sudanese population
por: Abdel Hamid, Muzamil M., et al.
Publicado: (2015)

Lipoprotein(a), family history of cardiovascular disease, and incidence of heart failure
por: Wang, Hai-Peng, et al.
Publicado: (2023)

Allergen extracts and recombinant proteins: comparison of efficiency of in vitro allergy diagnostics using multiplex assay on a biological microchip
por: Smoldovskaya, Olga, et al.
Publicado: (2016)

Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol
por: Gulayin, Pablo E., et al.
Publicado: (2022)

Low-density lipoprotein receptor gene mutation at Exon 2 and 4 in premature coronary artery disease in our population
por: Rehman, Saqibah, et al.
Publicado: (2019)

Pregnancy-related conditions and premature coronary heart disease in adult offspring
por: Qanitha, Andriany, et al.
Publicado: (2017)

Expression of adipocytokines in heart fat depots depending on the degree of coronary artery atherosclerosis in patients with coronary artery disease
por: Gruzdeva, Olga V., et al.
Publicado: (2021)

Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study
por: Fernández-Cidón, Bárbara, et al.
Publicado: (2021)

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
por: Björnson, Elias, et al.
Publicado: (2023)

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients
por: Hu, Ziyang, et al.
Publicado: (2021)

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
por: Gencer, Baris, et al.
Publicado: (2021)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6nokl8ufluueukjlg477rahgjm